Advances in the treatment of chronic kidney disease: Emerging role of SGLT-2 therapy

Moderator, Dr. Pelin Batur discusses advances in the treatment of chronic kidney disease and the emerging role of sodium glucose co-transporter 2 (SGLT-2) inhibitor therapy with expert nephrology consultants, Dr. Joseph V. Nally and Dr. Jerry Appel, in an 8 chapter video series.

Full Video

Video Chapters

 

6 minutes 0 seconds

Chapter 1: What’s new in the treatment of chronic kidney disease?

 

6 minutes 47 seconds

Chapter 2: Pathophysiology of glomerular damage in diabetes and chronic kidney disease

 

5 minutes 48 seconds

Chapter 3: Origins of sodium glucose cotransporter-2 (SGLT2) inhibitor use in kidney disease

 

8 minutes 39 seconds

Chapter 4: A closer look at the glomerulus and sodium glucose transporter

 

4 minutes 17 seconds

Chapter 5: Interventions and management of chronic kidney disease

 

3 minutes 54 seconds

Chapter 6: “What about the side effects, doc?”

 

6 minutes 11 seconds

Chapter 7: Clinical challenges

 

5 minutes 21 seconds

Chapter 8: Future directions for chronic kidney disease research and treatment

← Back to Conversations with Leaders